Skip to main content

Table 1 Baseline Characteristics

From: The association between serum chloride levels and chronic kidney disease progression: a cohort study

Variable

Quartile 1

N = 115

Quartile 2

N = 167

Quartile 3

N = 135

Quartile 4

N = 174

P-value

Chloride range (mEq/L)

[89–102)

[102–105)

[105–107)

[107–114]

 

Age (years)

72.0 (17.29)

75.2 (21.99)

73.4 (18.93)

73.2 (16.96)

0.75

Race

 White

93 (81)

129 (77)

104 (77)

130 (75)

0.25

 Black

13 (12)

26 (16)

19 (14)

26 (15)

0.66

 Hispanic

1 (1)

2 (1)

1 (1)

10 (6)

0.006

 Other

1 (1)

5 (3)

3 (2)

3 (2)

0.89

 Unknown

6 (5)

5 (3)

8 (6)

5 (3)

0.58

Smoking

 Current smoker

6 (5)

9 (5)

6 (4)

13 (7)

0.44

 Former smoker

48 (42)

77 (46)

69 (51)

74 (43)

0.87

 Non-smoker

52 (45)

76 (46)

55 (41)

74 (43)

0.50

 Unknown

9 (8)

5 (3)

5 (4)

13 (7)

0.73

Insurance

 Medicare

87 (76)

121 (72)

95 (70)

121 (70)

0.25

 Private

25 (22)

38 (23)

35 (26)

41 (24)

0.63

 Medicaid/Self

3 (3)

8 (5)

5 (4)

12 (7)

0.13

Female

46 (40)

63 (38)

44 (33)

70 (40)

0.95

Uses ACEi/ARB

74 (64)

98 (59)

87 (64)

125 (72)

0.06

Uses diuretics

83 (72)

103 (62)

68 (50)

91 (52)

<  0.001

Diabetes

68 (59)

86 (52)

76 (56)

85 (49)

0.17

Hypertension

104 (90)

149 (89)

125 (93)

164 (94)

0.12

CHF

24 (21)

50 (30)

30 (22)

26 (15)

0.039

eGFR,

ml/min per 1.73 m2

38.87 (18.4)

34.86 (16.81)

35.91 (19.17)

31.78 (20.22)

<  0.001

ACR, mg/g

123 (412.61)

137.02 (454.04)

134.53 (492)

232.2 (691.51)

0.009

Bicarbonate, mEq/L

26 (5.5)

26 (5)

24 (4)

23 (6)

< 0.001

Phosphate, mg/dL

3.6 (0.8)

3.6 (0.8)

3.6 (0.7)

3.7 (0.7)

0.52

Albumin, g/dL

4.2 (0.5)

4.1 (0.4)

4.1 (0.4)

4.0 (0.4)

< 0.001

Calcium, mg/dL

9.5 (0.7)

9.3 (0.6)

9.3 (0.7)

9.2 (0.6)

< 0.001

  1. Results are presented as n (%) or median (IQR). ACEi Angiotensin-converting enzyme inhibitor, ARB Angiotensin receptor blocker, ACR Urine albumin-to-creatinine ratio, CHF Congestive heart failure